logo
Share SHARE
FONT-SIZE Plus   Neg

US FDA Grants Approval For Reckitt Benckiser's Suboxone Sublingual Film

Reckitt Benckiser Pharmaceuticals Ltd (RB.L) Monday announced that the U.S. Food and Drug Administration, or the FDA, has granted approval for 4 mg dose and 12 mg dose of Suboxone sublingual film.

Suboxone sublingual film is indicated for maintenance treatment of opioid dependence, also known as prescription opioid painkiller and heroin addiction, a growing epidemic in the United States.

Opioid dependence is a chronic and progressive medical condition caused in part by the changes in the chemistry of the brain that can result from regular opioid drug use. Dependence on opioids has been defined as a chronic (long-term) brain disease by the World Health Organization and the National Institute on Drug Abuse. Once opioid dependence develops, it is a chronic condition that left untreated can be fatal.

The pharmaceutical company further added that it has developed the 4 mg and 12 mg strengths in an ongoing effort to help mitigate the risk of unintentional multi-dose pediatric exposure, which is a major public health concern associated with medications.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
JetBlue Airways is all set to begin direct flights to Cuba from New York beginning July 3. "The Rift delivers on the dream of consumer VR with compelling content, a full ecosystem, and a fully-integrated hardware/software tech stack," the Facebook-owned virtual reality technology firm said. Germanwings co-pilot Andreas Lubitz, who appears to have deliberately crashed the aircraft on French Alps, had rehearsed controlled descent on another flight that morning, investigators said. The crash has killed 150 people aboard the Germanwings Flight 9525 on March 24.
comments powered by Disqus
RELATED NEWS
Trade RB.L now with 
Follow RTT